IRCT20200623047902N3尚未招募未知
Bioequivalence study of Pirfenidone capsule 267mg (Pirfenzi) manufactured by Zistdaru Danesh company in healthy volunteers
Zistdaru Danesh Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-60)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Pirfenidone
研究者
相似试验
尚未招募
不适用
Study of absorption and elimination rate of Pirfenidone 200-mg Tablets in comparison with Pirfenidone brand Tablets (Pirfenex®).Bioequivalence study.IRCT20200407046981N30Modava pharmaceutical company24
招募中
不适用
In-vivo Bioequivalence Test of Pirfenidone tablet 200 mg Arang Pharma with brand drug (PIRFENEX® 200mg, Cipla, India)IRCT20200105046010N61Arang Pharm Co.24
招募中
不适用
Study of absorption and elimination rate of Biperiden 4-mg extended-release tablets in comparison with Biperiden brand tablets (Akineton®)IRCT20200407046981N44Vana Darou Gostar Pharmaceutical Company24
尚未招募
不适用
Bioequivalence evaluation of Fexofenadine Tablet 180 mg manufactured by Raha pharmaceutical companyIRCT20200625047913N6Hezareh Sevom Futuristic Pharmacist24
尚未招募
不适用
Bioequivalance study of Fexofenadine 180 mg TabletsIRCT20200513047423N6Sana Med24